Skip to content
CNS Clinical Research

Connecticut

CNS clinical trials in Connecticut

82 CNS studies are recruiting participants at sites in 15 cities across Connecticut as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Connecticut city with a recruiting study

By research area: Depression (28), Parkinson's Disease (22), Migraine (12), Schizophrenia (7), Epilepsy (5), Multiple Sclerosis (4), Bipolar Disorder (3), ADHD (1).

New Haven (41), Stamford (14), Farmington (10), Cromwell (6), Hartford (6), West Haven (4), North Haven (3), Waterbury (3), Milford (2), Branford (1), Darien (1), Norwich (1), Orange (1), Storrs (1), Westport (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Connecticut

Basic details from each study's public record (the 12 most recently updated of 82). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Open-Label Psilocybin Study in Transdiagnostic Population

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Yale University
    Recruiting in
    New Haven
    Registry record
    NCT06442423 · updated
  2. Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Cromwell
    Registry record
    NCT07226661 · updated
  3. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 85
    • All sexes
    Sponsor
    Cybin IRL Limited
    Recruiting in
    New Haven
    Registry record
    NCT06793397 · updated
  4. Healing Hearts: A Mindfulness App for Parents Navigating Divorce or Separation

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Connecticut
    Recruiting in
    Stamford
    Registry record
    NCT07871916 · updated
  5. A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Seaport Therapeutics
    Recruiting in
    Cromwell
    Registry record
    NCT07065240 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Connecticut on ClinicalTrials.gov.

Parkinson's disease: recently updated in Connecticut

  1. A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Stamford
    Registry record
    NCT06345729 · updated
  2. A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    • Phase 3
    • Ages 18 and older
    • Female participants
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    New Haven
    Registry record
    NCT06952504 · updated
  3. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    New Haven · Norwich
    Registry record
    NCT06623422 · updated
  4. An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Yale University
    Recruiting in
    North Haven
    Registry record
    NCT06996652 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Connecticut on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Connecticut

  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    New Haven
    Registry record
    NCT03816345 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Connecticut on ClinicalTrials.gov.

Migraine: recently updated in Connecticut

  1. Study of EVO756 in Adults With Migraine

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Evommune, Inc.
    Recruiting in
    New Haven · Stamford
    Registry record
    NCT07616128 · updated
  2. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Stamford
    Registry record
    NCT07816367 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Connecticut on ClinicalTrials.gov.

Ask about studies in Connecticut

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call